Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
FONAR Corporation is a medical devices business based in the US. FONAR Corporation shares (FONR) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$15.15|
|52-week range||$14.93 - $21.77|
|50-day moving average||$16.54|
|200-day moving average||$17.27|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.46|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-4.05%|
|1 month (2021-09-17)||-10.88%|
|3 months (2021-07-16)||-12.48%|
|6 months (2021-04-16)||-17.30%|
|1 year (2020-10-16)||-28.71%|
|2 years (2019-10-16)||-26.35%|
|3 years (2018-10-16)||23.66|
|5 years (2016-10-14)||19.74|
Valuing FONAR Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FONAR Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FONAR Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, FONAR Corporation shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
FONAR Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $21.2 million.
The EBITDA is a measure of a FONAR Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$89.9 million|
|Operating margin TTM||19.01%|
|Gross profit TTM||$43.5 million|
|Return on assets TTM||5.78%|
|Return on equity TTM||10.45%|
|Market capitalisation||$101.2 million|
TTM: trailing 12 months
There are currently 40,641 FONAR Corporation shares held short by investors – that's known as FONAR Corporation's "short interest". This figure is 13.8% down from 47,123 last month.
There are a few different ways that this level of interest in shorting FONAR Corporation shares can be evaluated.
FONAR Corporation's "short interest ratio" (SIR) is the quantity of FONAR Corporation shares currently shorted divided by the average quantity of FONAR Corporation shares traded daily (recently around 21968.108108108). FONAR Corporation's SIR currently stands at 1.85. In other words for every 100,000 FONAR Corporation shares traded daily on the market, roughly 1850 shares are currently held short.
However FONAR Corporation's short interest can also be evaluated against the total number of FONAR Corporation shares, or, against the total number of tradable FONAR Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case FONAR Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 FONAR Corporation shares in existence, roughly 10 shares are currently held short) or 0.0069% of the tradable shares (for every 100,000 tradable FONAR Corporation shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against FONAR Corporation.
Find out more about how you can short FONAR Corporation stock.
We're not expecting FONAR Corporation to pay a dividend over the next 12 months.
FONAR Corporation's shares were split on a 1:25 basis on 16 April 2007. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FONAR Corporation shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for FONAR Corporation shares which in turn could have impacted FONAR Corporation's share price.
Over the last 12 months, FONAR Corporation's shares have ranged in value from as little as $14.93 up to $21.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FONAR Corporation's is 1.0312. This would suggest that FONAR Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates four diagnostic imaging facilities in Florida; and manages 35 MRI scanning facilities, including 22 facilities located in New York and 13 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.